Journal article
The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis
Abstract
CONTEXT: Gemcitabine/platinum chemotherapy is the most widely used first-line regimen for metastatic urothelial carcinoma, and the potential improvement of adding taxanes needs to be clarified.
OBJECTIVE: To study the survival impact of taxane plus gemcitabine/platinum compared with gemcitabine/platinum alone as upfront therapy.
Authors
Giannatempo P; Pond GR; Sonpavde G; Raggi D; Naik G; Galsky MD; Bellmunt J; Necchi A
Journal
European Urology, Vol. 69, No. 4, pp. 624–633
Publisher
Elsevier
Publication Date
April 2016
DOI
10.1016/j.eururo.2015.09.051
ISSN
0302-2838